Efficacy and safety of novel twincretin tirzepatide a dual GIP and GLP-1 receptor agonist in the management of type-2 diabetes: A Cochrane meta-analysis
Background: Till date, there is no Cochrane meta-analysis available which has analyzed efficacy and safety of tirzepatide in type-2 diabetes. This meta-analysis was undertaken to address this knowledge gap. Methods: Electronic databases were searched for randomized controlled trials (RCTs) involving...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Col·lecció: | Indian Journal of Endocrinology and Metabolism |
| Matèries: | |
| Accés en línia: | http://www.ijem.in/article.asp?issn=2230-8210;year=2021;volume=25;issue=6;spage=475;epage=483;aulast=Dutta |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|